https://www.selleckchem.com/pr....oducts/ethyl-3-amino
No differences were observed between the three monitoring strategies in QTc prolongation (p = 0.864). In the control group, all but one ECG registry with the smart device allowed QTc measurement and mean QTc did not differ between both techniques (p = 0.612), displaying a moderate reliability (ICC 0.56 [0.19-0.76]). Time of ECG registry was significantly longer for the 12-lead ECG than for handheld device in both cohorts (p 0.001). QTc monitoring with KardiaMobile-6L in COVID-19 patients was feasible.
Like
Comment
Share
